EUVIMEDEUVIMED entdecken
Open Access

Early Implementation of Doxycycline Postexposure Prophylaxis at an Infectious Diseases Clinic in the Southern United States

Emily D Niehaus iD, Avi Kenny, Charles M Burns, Mehri S McKellar, Justin Frye, Nwora Lance Okeke

AIDS Patient Care and STDs · 01.08.2026 · 40 (8) · 288-296

DOI: 10.1177/10872914261461631 ↗

Kurz gefasst

Fachartikel in der Zeitschrift AIDS Patient Care and STDs, online erschienen am 16.06.2026. Verfasst von Emily D Niehaus und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Duke University, Durham, NC, USA. Hauptthemen laut MEDLINE: Doxycycline, Post-Exposure Prophylaxis, HIV Infections, Anti-Bacterial Agents. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, Interdisciplinary Research Training Grant in AIDS Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Doxycycline postexposure prophylaxis (DoxyPEP) is an emerging strategy to prevent bacterial sexually transmitted infections (STIs) among men who have sex with men (MSM) and transgender women (TGW). We evaluated early DoxyPEP implementation in a university-affiliated infectious diseases clinic providing HIV and pre-exposure prophylaxis (PrEP) care in Durham, North Carolina. This retrospective study included two overlapping cohorts: (1) patients prescribed DoxyPEP through December 31, 2024, to characterize early prescribing and follow-up with contextual clinic comparison; and (2) MSM and TGW diagnosed with a bacterial STI between July 1, 2023, and December 31, 2024, in whom factors associated with DoxyPEP receipt were evaluated using mixed-effects logistic regression. Among 219 patients prescribed DoxyPEP, 41% had a bacterial STI in the preceding year, more frequently among people with HIV (PWH) than PrEP users (51% vs. 30%, p = 0.002). Although PWH comprised 90% of the clinic population, they accounted for 53% of DoxyPEP recipients, signaling disproportionate adoption by HIV status. Among 276 MSM/TGW patients with a bacterial STI during the study period, 26% were prescribed DoxyPEP during a median follow-up of 11 months (interquartile range: 6–14). PrEP use (adjusted odds ratio [aOR]: 11.1, 95% confidence interval [CI]: 2.97–41.2) and encounters after Centers for Disease Control and Prevention guideline release (aOR: 2.46, 95% CI: 1.03–5.83) were associated with DoxyPEP receipt. Recurrent bacterial STI incidence prior to DoxyPEP initiation was 51 per 100 person years. Despite increasing uptake over time, missed opportunities for DoxyPEP prescribing were observed following STI diagnoses, particularly among PWH. Targeted strategies are needed to support integration of DoxyPEP into routine HIV care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxycyclinePost-Exposure ProphylaxisHIV InfectionsAnti-Bacterial AgentsSexually Transmitted Diseases, BacterialHumansMaleFemaleRetrospective StudiesAdultNorth CarolinaAmbulatory Care FacilitiesHomosexuality, MaleTransgender PersonsMiddle AgedSexual and Gender MinoritiesPre-Exposure ProphylaxisYoung Adult

Stichwörter der Autor:innen

DoxyPEPSTI preventionpre-exposure prophylaxissexually transmitted infections

Substanzen

DoxycyclineAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Medicine, Duke University, Durham, NC, USA.
  • Department of Biostatistics & Bioinformatics, Duke University, Durham, NC, USA.
  • Duke Global Health Institute, Duke University, Durham, NC, USA.
  • Department of Population Health Sciences, Duke University, Durham, NC, USA.

ORCID-Profile: Emily D Niehaus

Förderung

  • NIAID NIH HHS
  • Interdisciplinary Research Training Grant in AIDS Research

Zitieren

APA

Niehaus, E. D., Kenny, A., Burns, C. M., McKellar, M. S., Frye, J., & Okeke, N. L. (2026). Early Implementation of Doxycycline Postexposure Prophylaxis at an Infectious Diseases Clinic in the Southern United States. AIDS Patient Care and STDs, 40(8), 288-296. https://doi.org/10.1177/10872914261461631

Vancouver

Niehaus ED, Kenny A, Burns CM, McKellar MS, Frye J, Okeke NL. Early Implementation of Doxycycline Postexposure Prophylaxis at an Infectious Diseases Clinic in the Southern United States. AIDS Patient Care and STDs. 2026;40(8):288-296. doi:10.1177/10872914261461631

BibTeX
@article{Niehaus2026,
  author = {Niehaus, Emily D and Kenny, Avi and Burns, Charles M and McKellar, Mehri S and Frye, Justin and Okeke, Nwora Lance},
  title = {Early Implementation of Doxycycline Postexposure Prophylaxis at an Infectious Diseases Clinic in the Southern United States},
  journal = {AIDS Patient Care and STDs},
  year = {2026},
  volume = {40},
  number = {8},
  pages = {288--296},
  doi = {10.1177/10872914261461631}
}
Kostenlos starten →